Analytical testing is required in almost every stage of pharmaceutical research and development and production, from testing on raw materials, to quality control and dosage form of in-process material and finished products. Biopharmaceutical manufacturing industry uses analytical testing services/solutions to improve productivity, characterize biologics/biosimilars, optimize & monitor processes, and provide real-time product quality control. In short, pharmaceutical analytical testing play an important role in the biopharmaceutical manufacturing.
Market Dynamics:
Increase in demand for analytical testing services/solutions, rise in number of drug approvals and clinical trials, increase in trend of outsourcing laboratory testing services, government initiatives to strengthen analytical testing capabilities, and the outbreak of COVID-19 are some major factors expected to aid in the growth of the global pharmaceutical analytical testing market.
For instance, in July 2020, Alfa Chemistry Testing Lab launched the customized pharmaceutical analytical service for companies involved with new drug development.
Moreover, in February 2022, The Center for Breakthrough Medicines (CBM) opened their new analytical testing services laboratories to address growing capacity needs in the supply-constrained cell and gene therapy market. Around 2,500 submissions are currently under review in the FDA’s cell & gene therapy pipeline. By 2025, the Food and Drug Administration (FDA) expects to receive upwards of 200 investigational new drug (IND) applications for cell and gene therapies annually, with an estimated approval of 10 to 20 cell and gene therapies each year.
Key features of the study:
Detailed Segmentation:
Table of Contents:
*Browse 24 market data tables and 28 figures on "Global Pharmaceutical Analytical Testing Market” - forecast to 2028
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients